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Objectives We describe a noninvasive method of detecting and quantifying left atrial (LA) wall injury after pulmonary vein
antrum isolation (PVAI) in patients with atrial fibrillation (AF). Using a 3-dimensional (3D) delayed-enhancement
magnetic resonance imaging (MRI) sequence and novel processing methods, LA wall scarring is visualized at
high resolution after radiofrequency ablation (RFA).
Background Radiofrequency ablation to achieve PVAI is a promising approach to curing AF. Controlled lesion delivery and
scar formation within the LA are indicators of procedural success, but the assessment of these factors is limited
to invasive methods. Noninvasive evaluation of LA wall injury to assess permanent tissue injury may be an
important step in improving procedural success.
Methods Imaging of the LA wall with a 3D delayed-enhanced cardiac MRI sequence was performed before and 3 months
after ablation in 46 patients undergoing PVAI for AF. Our 3D respiratory-navigated MRI sequence using parallel
imaging resulted in 1.25  1.25  2.5 mm (reconstructed to 0.6  0.6  1.25 mm) spatial resolution with
imaging times ranging 8 to 12 min.
Results Radiofrequency ablation resulted in hyperenhancement of the LA wall in all patients post-PVAI and may repre-
sent tissue scarring. New methods of reconstructing the LA in 3D allowed quantification of LA scarring using au-
tomated methods. Arrhythmia recurrence at 3 months correlated with the degree of wall enhancement with
13% injury predicting freedom from AF (odds ratio: 18.5, 95% confidence interval: 1.27 to 268,
p  0.032).
Conclusions We define noninvasive MRI methods that allow for the detection and quantification of LA wall scarring after RF
ablation in patients with AF. Moreover, there seems to be a correlation between the extent of LA wall injury and
short-term procedural outcome. (J Am Coll Cardiol 2008;52:1263–71) © 2008 by the American College of
Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.05.062(
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otrial fibrillation (AF) is a growing clinical problem with
normous impact on both short-term quality of life and
ong-term survival (1,2). Radiofrequency ablation (RFA)
argeting the pulmonary veins’ ostia and antra has been
roven to be effective in managing patients with AF (3–5).
ontrolled lesion delivery and scar formation within the left
trium (LA) are indicators of procedural success, but the
ssessment of these factors is limited to invasive methods
rom the *Radiology Department and the †Division of Cardiology, Internal Medi-
ine, University of Utah School of Medicine, and the ‡Bioengineering Department,
niversity of Utah, Salt Lake City, Utah. Drs. Dibella, Parker, and Kholmovski are
artially supported by grants from Siemens Medical Corporation.r
Manuscript received February 22, 2008; revised manuscript received April 11,
008, accepted May 5, 2008.6). As a result, a noninvasive evaluation of LA wall injury
o assess permanent tissue injury may be an important step
n improving procedural success.
See page 1272
Delayed-enhancement cardiovascular magnetic resonance
maging (DE-CMRI) is an established noninvasive clinical
ethod for characterizing tissue in a variety of cardiac
isease processes, including after myocardial infarction and
njury due to myocarditis (7–14). Contrast enhancement in
njured tissue using magnetic resonance imaging (MRI)
ccurs because of altered washout kinetics of gadolinium
elative to the normal surrounding tissue. Magnetic reso-
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fully used to detect tissue injury
caused by radiofrequency (RF)
lesion formation, although data
are limited. Animal studies have
shown acute RF lesions in the
right ventricle in dogs as a result
of heat-related changes in T1 and
T2 parameters in the necrotic
myocardium (15). Formation of
RF lesions on the epicardium of
dogs also has been characterized in
several phases up to 12 h after
injury using gadolinium-enhanced
MRI and right ventricular en-
hancement correlated with histo-
pathology showing coagulation
necrosis with loss of cellular and
vascular architecture (16). In hu-
mans, Peters et al. (17) reported
on their initial experience using
3-dimensional (3D) DE-CMRI
to detect LA scar 1 to 3 months
after AF ablation, and a case of
left ventricular (LV) injury from
previous RF ablation in a patient
treated for idiopathic LV tachy-
cardia also has been reported
(18).
Although these data suggest
that MRI is well suited to pro-
ide important noninvasive evaluation of RFA lesions,
uman studies are lacking and its clinical role is still
ndefined. This study sought to detect and evaluate LA wall
njury in patients with AF after PVAI using novel MRI
ethods and image processing. Results discussed here may
elp better define procedure outcome, guide follow-up
reatment, and develop strategies to avoid complications.
ethods
atients. Fifty-three patients referred to the University of
tah for PVAI between December 2006 and July 2007 were
nrolled in this study. The protocol was approved by the
nstitutional Review Board at the University of Utah and
as compliant with the Health Insurance Portability and
ccountability Act of 1996. After informed consent was
btained, patients underwent pre-PVAI MRI scanning to
efine the PVs, location of the esophagus, LA anatomy, and
haracterization of the LA wall tissue. The MRI was
epeated 3 months after ablation in all patients.
After the procedure, patients continued anticoagulation
herapy with warfarin to maintain an international normal-
zed ratio of 2.0 to 3.0 for a minimum of 3 months. Patients
ere assessed after 3 months to determine the success of the
Abbreviations
and Acronyms
3D  three-dimensional
AF  atrial fibrillation
CI  confidence interval
DE-CMRI  delayed-
enhancement cardiac
magnetic resonance
imaging
ECG  electrocardiogram
FLASH  fast low angle
shot
GRAPPA  generalized
autocalibrating partially
parallel acquisitions
LA  left atrium/atrial
LV  left
ventricle/ventricular
MRI  magnetic resonance
imaging
OR  odds ratio
PVAI  pulmonary vein
antrum isolation
RFA  radiofrequency
ablation
RF  radiofrequency
TE  echo time
TI  inversion time
TR  repetition timeblation procedure. Success was defined as a lack of late AF Lecurrence while off antiarrhythmic medications. Event
onitors were placed for a minimum of 2 months after their
VAI. Patients were instructed to activate the monitors any
ime they felt symptomatic. To confirm the absence of
symptomatic AF, all patients received a 48-h Holter
lectrocardiogram (ECG) recording at the 3-month follow-
p. Recurrences were determined from patient reporting,
vent monitoring, Holter monitoring, and ECG data.
ecurrent AF was defined as a symptomatic or asymptom-
tic detected episode lasting 15 s.
ulmonary vein isolation procedure. The PVAI under
ntracardiac echocardiogram guidance was performed. A
0-F, 64-element, phased-array ultrasound catheter
AcuNav, Siemens, Mountain View, California) was used to
isualize the interatrial septum and to guide the transseptal
uncture. A circular mapping catheter (Lasso, BioSense
ebster, Diamond Bar, Colorado) and an ablation catheter
ere inserted into the LA. An intracardiac echocardiogram
as used to define the PV ostia and their antra and to help
osition the circular mapping catheter and ablation catheter
t the desired sites. Temperature and power were set to 50°
nd 50 W (pump flow rate at 30 ml/min), respectively. The
F delivery was interrupted in the case of impedance
ncrease or if a sudden increase in microbubble density was
bserved during ablation. All study patients underwent
VAI (19) in addition to LA posterior wall and septal
ebulking.
elayed-enhancement MRI acquisition sequence. All
articipants underwent MRI studies on a 1.5-T Avanto
linical scanner (Siemens Medical Solutions, Erlangen,
ermany) using a phased-array receiver coil 24 to 72 h
efore PVAI. The protocol included sequences to define the
natomy of the LA and pulmonary veins. The anatomy was
valuated using the contrast-enhanced 3D fast low angle
hot (FLASH) sequence and the cine true-fast imaging
ith steady state precession sequence. Typical acquisition
arameters for 3D FLASH scan were: breath-hold in
xpiration, a transverse (axial) imaging volume with voxel
ize  1.25  1.25  2.5 mm, repetition time (TR)  3.1
s, echo time (TE)  1.0 ms, and parallel imaging using
he generalized autocalibrating partially parallel acquisitions
GRAPPA) technique with reduction factor R  2 and 32
eference lines, scan time 14 s. The 3D FLASH scan was
cquired twice: pre-contrast and during a first pass of
ontrast agent (Multihance, Bracco Diagnostic Inc., Prince-
on, New Jersey), intravenous injection of a dose of 0.1
mol/kg body weight, 2-ml/s injection rate, followed by a
5-ml saline flush). Timing of the first pass scan was defined
sing a MRI fluoroscopic scan.
Complete coverage of the LA was achieved with 16 to 22
ransverse 2-dimensional slices acquired during retrospec-
ive ECG-gated, cine pulse sequence. All of the images
ere acquired during breath-hold in expiration (1 or 2 slices
er breath-hold depending on the subject heart rate and
olerance to breath-holding) and were used to evaluate the
A morphology during the cardiac cycle. Typical scan
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October 7, 2008:1263–71 MRI Method to Define Atrial Wall Injuryarameters were: 6-mm slice thickness, no gap between
lices, pixel size  2.0  2.0 mm, TR/TE  2.56/1.03 ms,
RAPPA with R  2 and 44 reference lines, 15 views/
egment.
Delayed enhancement MRI was used to identify fibrous
issue in the LA. The DE-CMRI was acquired 15 min after
he contrast agent injection using a 3D inversion recovery-
repared, respiration-navigated, ECG-gated, gradient echo
ulse sequence. Typical acquisition parameters were as
ollows: free breathing using navigator gating, a transverse
maging volume with voxel size  1.25  1.25  2.5 mm
reconstructed to 0.625  0.625  1.25 mm), TR/TE 
.3/2.3 ms, inversion time (TI)  230 to 270 ms, and
RAPPA with R  2 and 32 reference lines. Electrocar-
iogram gating was used to acquire a small subset of
hase-encoding views used during the diastolic phase of the
A cardiac cycle. The time interval between the R-peak of
he ECG and the start of data acquisition was defined using
he cine images of the LA. Fat saturation was used to
uppress the fat signal. The TE of the scan (2.3 ms) was
hosen so that fat and water are out of phase and the signal
ntensity of partial volume fat-tissue voxels was reduced,
hich allowed for improved delineation of the LA wall
oundary. The TI value for the DE-CMRI scan was
dentified using a scout scan. Typical scan time for the
E-CMRI study was 5 to 10 min depending on subject
espiration and heart rate. If the first acquisition did not
ave an optimal TI or had substantial motion artifacts, the
can was repeated.
mage processing and analysis. All MR images were
valuated and interpreted by 2 independent operators expe-
ienced in CMRI. Processing of the MRI digital imaging
nd communications in medicine (DICOM) formatted data
ets were performed using OsiriX (open-source) for visual-
zation, whereas quantification of images was performed
sing Matlab (Mathworks, Inc., Natick, Massachusetts).
he LA data from 3D DE-CMRI acquisitions were eval-
ated slice by slice and using volume rendering tools. These
mages were segmented and rendered, which allowed for
nique visualization of LA wall RF injury patterns using the
ntire data set and facilitated correlation with 3D CARTO
mages. Visualization was performed using smooth table
pacity.
In patients who underwent post-procedural MRI scans,
he relative extent of injury within the volume was measured
sing a threshold-based lesion detection algorithm. In all
mages, the epicardial and endocardial borders were manually
ontoured using custom image display and analysis software
ritten in Matlab. Care was made in 2-dimensional tracings
f the endocardial and epicardial walls to confine the region
f interest to only the LA wall and to avoid the blood pool,
articularly on the right side, where a navigator-induced
rtifact was present in some patient scans. Normal and
njured tissue were defined based on a bimodal distribution
f pixel intensities within the LA wall. The first mode of
ower pixel intensities was chosen as normal tissue. Injured Pissue was defined at 3 standard deviations above the normal
issue mean pixel intensity. Regions defined as lesion were
isualized independently to ensure appropriateness of lesion
etection. The LA lesion area for each slice was summed for
he entire scan and reported as a ratio of lesion volume to
otal LA wall volume. For selected patients with character-
stic patterns of lesion formation observed in the OsiriX 3D
isualizations, image masks of injured regions were recon-
tructed into 3D volumes for comparison with the OsiriX
isualizations. The investigators were blinded during the
nalysis of all imaging and electrophysiology data.
ollow-up. All patients were monitored overnight on a
elemetry unit after the procedure. Warfarin (INR 2 to 3)
as restarted in all patients the day of PVAI, and was
ontinued for a minimum of 3 months in paroxysmal and
or 6 months in persistent and permanent AF patients.
atients were followed up in the outpatient clinic 3 months
ost-ablation, at which point they underwent an MRI scan
o assess for PV stenosis, degree of chronic LA scarring, and
olter monitor recording for 24 to 48 h.
tatistical methods. Normal continuous variables are pre-
ented as mean  SD. Continuous data were analyzed by
he Student t test to test for significant differences. Chi-
quare tests were used to test for differences in categorical
easurements. Differences were considered significant at
 0.05. Statistical analysis was performed using the SPSS
5.0 statistical package (SPSS Inc., Chicago, Illinois).
atient Demographics,ummary by Response to Procedure
Table 1 Patient Demographics,Summary by Response to Procedure
Responders
(n  35)
Nonresponders
(n  11) p Value*
Type of atrial fibrillation 0.118
Paroxysmal 19 (54.3%) 3 (27.3%)
Persistent 16 (45.7%) 8 (72.7%)
Gender
Female 12 (34.3%) 5 (45.5%) 0.503
Male 23 (65.7%) 6 (54.5%)
Hypertension 18 (2.9%) 3 (27.3%) 0.161
Diabetes 5 (14.3%) — 0.184
Coronary artery disease 4 (11.4%) 2 (18.2%) 0.562
History of smoking 5 (17.1%) 4 (36.4%) 0.107
Valve surgery 1 (2.8%) — 0.571
Myocardial infarction 2 (5.7%) 1 (9.1%) 0.692
Mitral stenosis 4 (11.4%) — 0.241
Age (yrs) 63.1 11.9 71.4 11.4 0.048
Left ventricular ejection fraction (%) 57.1 4.9 49.5 9.6 0.002
Left atrial area, pre-PVAI (cm2) 20.1 8.5 24.9 6.4 0.147
Left atrial volume, pre-PVAI (cm3) 84.8 24.5 128.3 29.8 0.001
Antiarrhythmic medications
None 19 (54.3%) 7 (63.6%) 0.567
One medication 12 (34.3%) 2 (18.2%)
Multiple medications 4 (11.4%) 2 (18.2%)VAI  pulmonary vein antrum isolation.
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atients. Fifty-three patients who underwent PVAI for
reatment of AF during the study period and completed the
RI scanning protocol were included in the analysis. Seven
f the 53 patients were excluded because of inadequate MR
mages. The patients removed included 6 with poor image
uality on the pre- or post-ablation scans and 1 who
eceived an insufficient dose of intravenous contrast. Poor
mage quality resulted from patient motion and significant
ardiac arrhythmia. In 1 case, navigator signal interference
recluded accurate analysis. Results from the remaining 46
atients were included in the data.
Table 1 shows the patient demographics for responders
nd nonresponders to PVAI treatment. Statistically signif-
Figure 1 Left Atrial Injury Before PVAI and 3 Months After PVA
Left panels show LA wall slices at baseline (A) and 3 months after PVAI (B) on 3D
Patient #1 before and after PVAI in multiple views (posterior, right, left, and super
clearly seen (yellow arrows) in regions subjected to RF ablation and suggests sca
onance imaging; LA  left atrial/atrium; MRI  magnetic resonance imaging; PVAIcant differences were seen among the study populations for
ge, LV ejection fraction, LA area, and LA volume and are
onsistent with prior published data (20–34).
E-CMRI visualization and quantification. Hyperen-
ancement in the left atrium was not seen in patients at
aseline prior to the ablation. Mild signal in the LA wall
as seen in 4 patient scans (8.7%); however, it was clearly
ower intensity than scans post-ablation injury. In addition,
he pre-ablation enhancement did not meet the threshold
or hyperenhancement determined by our quantification algo-
ithm, which was modeled after previously published methods
35,36). Clear contrast enhancement was seen in all (46 of 46,
00%) of the post-ablation images, most commonly in the
osterior LA wall, interatrial septum, and surrounding the
3D DE-CMRI
ated DE-CMRI in 4 different patients. Right panels show 3D rendering of LA in
onstructed from MRI slice data. Post-PVAI hyperenhancement of LA wall is
3D  three-dimensional; DE-CMRI  delayed-enhancement cardiac magnetic res-
lmonary vein antrum isolation; RF  radiofrequency.I on
navig
ior) rec
rring.
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October 7, 2008:1263–71 MRI Method to Define Atrial Wall Injuryulmonary veins (Fig. 1). Two experienced independent oper-
tors evaluated the presence or absence of contrast enhance-
ent on DE-CMRI with agreement in all cases. Enhance-
ent within the right pulmonary veins occurred in some
atients. This was caused by the navigator RF pulse located
ver the right hemidiaphragm and did not reflect tissue injury.
his navigator-induced interference was differentiated from
nhancement by its location and intensity. A recent change
ade to the pulse sequence has resulted in a complete removal
f the navigator interference (data not shown).
Figure 1 shows MRI slices for 4 separate patients at
aseline and 3 months after PVAI. As noted, the injury
o the LA wall is largely located in the posterior wall, PV
stia, and interatrial septum. However, degree of injury
aried greatly among patients. The anterior LA wall was
onsistently spared and free of MRI evidence of injury in
ll patients, which is consistent with current strategies for
atheter ablation of AF. Figure 1 also shows an example
f 3D visualization of the LA wall in Patient #1 before
nd after ablation in 4 different orientations: posterior,
ight, left, and superior views.
Figure 2 shows LA injury detection using the semiau-
omated computer algorithm. When injury as identified
y the computer algorithm is overlaid with 3D visualiza-
ion, there is a strong correlation between the observed
njury patterns and the region identified as scar by the
lgorithm. Figure 3 shows the overlay for 1 patient in 3
imensions. An LA injury identified by the computer
lgorithm (blue) matches regions of hyperenhancement
white) in the MRI visualization. Similar correlation
Figure 2 Automated Quantification of Chronic LA Injury 3 Mont
Left atrial wall injury was determined using a threshold based on the defined norm
set of slices from the 3D DE-CMRI from Patient #1 (Fig. 1). Reconstruction in 3D o
methods, LA injury volume can be determined and calculated as a percentage of t
Figure 1.etween MRI visualization and algorithm detection were
een for all patients. This segmentation algorithm in
onjunction with the DE-CMRI data allowed LA wall
njury to be quantified as a percentage of the total LA
all volume.
uantification of LA wall injury and patient out-
ome. At 3 months, 35 of 46 patients (76.1%) remained
ree of AF recurrence. All who suffered AF recurrences were
laced back on antiarrhythmic drugs. Although a higher
ercentage of individuals who did not respond to therapy
nd suffered recurrence had persistent/permanent AF (8 of
1, 72.7%) versus those who responded to therapy (16 of 35,
5.7%), this difference failed to reach statistical significance
p  0.118).
A large difference was seen between the percentage of
A wall injury (as determined by MRI and semiauto-
ated quantification) between responders and nonre-
ponders to PVAI (Fig. 4). In patients who responded to
blation, the average LA wall injury was 19.3  6.7%,
hereas in those who did not respond, the average LA
all injury was 12.4  5.7% (p  0.004). The strong
ssociation between average LA wall injury and recur-
ence persisted when stratifying patients by the first and
econd quartiles. Using the first quartile (LA wall injury 
3%), patients with large scars were 18.5  less likely to
uffer recurrence of AF (odds ratio [OR]: 18.5, 95%
onfidence interval [CI]: 1.27 to 268, p  0.032). After
ontrolling for age, gender, ablation time, and type of AF,
arge scar areas strongly predicted the absence of recurrences
adjusted OR: 83.7, 95% CI: 2.013 to 3,481.1, p  0.022).
fter PVAI
l regions. Panels 1 to 16 show extent of injury at 5 standard deviations in a sub-
full set of data is shown in the right panels (3D PA and RL views). Using these
wall volume. PA  posterior-anterior; RL  right-left; other abbreviations as inhs A
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MRI Method to Define Atrial Wall Injury October 7, 2008:1263–71sing the second quartile (median) as the cutoff for large
car areas, the protective association between large scar areas
nd recurrences was smaller but still persisted (p  0.045).
iscussion
ain findings. In this study, we show LA injury after
VAI visualized by 3D DE-CMRI at high resolution using
ur novel imaging approach and processing methods. Left
trial wall injury resulting from RF ablation 3 months after
VAI was seen in every patient with a tissue injury pattern
Figure 3 Overlay Images of LA Wall Injury
Panels 1A to 1D are 4 example LA slices from the 3D DE-CMRI from Patient #1 (F
using a 3-SD cutoff value (blue transparency) overlaying MRI. Right panels show 3
mated methods should match and overlay hyperenhanced areas (white) of true in
ment is attributable to navigator interference, not injured tissue, as we position th
anatomical orientation and are excluded from raw data used to produce injury mas
Figure 4 Association Between Atrial Fibrillation Recurrences and
Success According to LA Wall Injury After Catheter
Patients with minimal scar formation at 3 months after the procedure (13% of LA
recurrence of atrial fibrillation, whereas patients with moderate scar formation at 3
Abbreviations as in Figure 1.eflecting location of RF energy delivery sites. In addition,
njury on MRI seems to reflect tissue scarring, and the
egree of scarring correlates with procedural outcomes.
E-CMRI detects tissue injury from RFA. In patients
ith ischemic cardiomyopathy, DE-CMRI is used rou-
inely to accurately detect and size infarcted myocardium. It
s arguably the gold standard viability study and accurately
redicts hibernating myocardium and response to revascu-
arization (37,38). Performing DE-CMRI to detect LA wall
njury is challenging as the LA is a thin wall structure
that show close correlation of LA injury as determined by automated methods
rlay of full data set (3D PA and RL). LA injury mask (blue) determined by auto-
DE-CMRI. Although the left pulmonary veins are white on MRI, this enhance-
gator over the right hemidiaphragm. The PVs are shown here only to help with
utomated methods. Abbreviations as in Figures 1 and 2.
cal
d PVAI
ardial volume enhancement on DE-MRI) had low procedural success and a high
hs had very high procedural success and a low recurrence of atrial fibrillation.ig. 1)
D ove
jury on
e navi
k by aClini
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October 7, 2008:1263–71 MRI Method to Define Atrial Wall Injuryompared with the LV, and thus requires better spatial
esolution while maintaining adequate contrast-to-noise ratio
nd signal-to-noise ratio. The MRI pulse sequence we use is a
D high-resolution sequence similar to one reported on by
eters et al. (17) and achieves spatial resolution much greater
han that typical for 2D delayed enhancement used in LV
iability studies. In addition, we were able to take advantage of
arallel imaging to significantly reduce the scan time and, as a
esult, reduce motion artifact.
Processing enhancements here greatly facilitated a more
omprehensive evaluation of LA wall injury from images
cquired from MRI images. Using a DICOM image editor,
e developed methods to view the entire LA wall injury
olume rendered in 3D from the slice data set, which
acilitated comparisons with other important 3D image
ata, including CARTO-derived voltage maps, sites of RF
nergy deposition, and the LA angiogram. Visualization of
A wall injury in 3D also improved assessment of lesion
onfluence and atrial debulking resulting from PVAI.
njury patterns on DE-CMRI and tissue scarring in the
A. Effective injury to the LA wall and permanent tissue
njury are important for procedural success (39). Although
nvasive electroanatomical mapping is an important tool to
elp establish tissue ablation during the procedure, lesion
ecovery and incomplete sampling limit accurate and com-
rehensive assessment of permanent tissue injury. Nonin-
asive detection of LA wall injury using DE-CMRI is a
ecent advancement that reliably detected injury at 3 months
Figure 5 Delayed-Enhancement MRI Scans Acquired 3 Month
After a First (Failed) Procedure and a Second (Succ
Incomplete scar formation located near the antrum of the pulmonary veins after fa
nary vein antrum (purple) correlated with incomplete electrical isolation of the left
shows complete scar formation (white/orange) isolating the pulmonary veins. Bot
Abbreviations as in Figure 1.n all of our patients (46 of 46 patients, no interobserver rariability). In addition, the entire LA wall is visualized on
D MRI and serial evaluation is safe and noninvasive.
There are a number of potential applications of our
isualization technique and analysis. One such technique
ould analyze potential reasons for AF recurrence, such as
hat when loss of electrical isolation after PVAI has oc-
urred (40). Visualization of the pulmonary veins and LA
sing 3D image processing allows for the scar pattern to be
ssessed and subsequent isolation procedures to be planned.
igure 5 shows visualizations of DE-MRI scans of 2
atients acquired 3 months after a failed PVAI.
These patients elected to undergo a second ablation
rocedure and had a second DE-MRI scan acquired after
hat procedure. Three-dimensional segmentation of the LA
as performed according to the methods described. Incom-
lete scar formation can be seen near the antrum of the
ulmonary veins after the failed PVAI procedure. This gap
n RF lesions at the pulmonary vein antrum (purple)
orrelated with incomplete electrical isolation of the left
uperior vein (as determined by electrophysiology study at
he time of the second procedure). After the repeat proce-
ure, the MRI shows complete scar formation around the
stia of the left superior vein (Figs. 1C, 1D, 2C, 2D, and 5)
n both patients. Three months after the second procedure,
oth patients were free of AF (as determined by 8-day
olter recordings and patient self-report). In such an
pplication, 3D processing provides an advantage over
raditional 2D visualization because it allows for the spatial
ul) Procedure
olation was noted in both patient examples. The gap in RF lesions at the pulmo-
ior pulmonary vein. Delayed-enhancement MRI at 3 months after the repeat PVAI
ents were free of AF at follow-up. Posterior and left lateral views are shown.s
essf
iled is
super
h patielationships and complex geometry of the LA to be better
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MRI Method to Define Atrial Wall Injury October 7, 2008:1263–71ppreciated. This will likely lead to improved procedure
lanning and a lower recurrence rate of AF.
A wall injury on MRI predicted procedural out-
ome. Although all patients in this study had detectable
njury on 3D DE-CMRI 3 months after ablation, the extent
f injury varied significantly. When we applied our auto-
ated algorithm to quantify LA wall injury, degree of injury
as significantly different between responders and nonre-
ponders (Table 2). After controlling for age, gender, AF
henotype, LA size, and LA volume, patients with scar
atios 13% are 18.5 times more likely to have a
avorable outcome and freedom from AF at 3 months
OR: 18.5, 95% CI: 1.27 to 268, p  0.032). These data
uggest that degree of LA wall scarring predicts proce-
ural success. Our findings validate preliminary reports
hat seem to show that procedural outcome correlates
ith overall enhancement (41).
The overall degree of scar may have important implica-
ions to the lesion type and subsequent interruption of PV
o LA conduction. Interruption of PV to LA conduction
as been an important component of procedural success.
erma et al. (40) reported recurrent AF after PVAI in
atients with more PV-to-LA conduction and shorter
A-to-PV delays. In comparison, the majority of patients
aintaining sinus rhythm off antiarrhythmic drugs showed
o recurrent PV-to-LA conduction and significantly longer
A-to-PV delay. These results are supported by an earlier
tudy by Ouyang et al. (42) showing recovery of PV
onduction in patients with recurrent atrial tachyarrhyth-
ias after PVAI. Closing the conduction gaps on repeat
rocedure later successfully eliminated the arrhythmias.
hese data suggest that overall lesion permanence and
omplete PV isolation may be important procedural goals.
he findings we present here also seem complimentary to
his previous work and may indicate that degree of scarring
n DE-CMRI may represent a noninvasive manner of
stimating the atrial lesion type and the subsequent electri-
al isolation (40,42–44).
tudy limitations. Although the outcomes data in this
tudy were statistically significant, the sample size was
elatively small. In addition, 3D MRI in this study was
erformed on a 1.5-T scanner. Significant improvements in
atients at 3-Month Follow-Up
Table 2 Patients at 3-Month Follow-Up
Responders
(n  35)
Nonresponders
(n  11) p Value*
Percent LA wall injury 19.3 6.7 12.4 5.7 0.004
Degree of scar formation
Minimal scar formation
(13% of volume enhancement)
3 (8.6%) 8 (72.7%) 0.001
Moderate scar formation
(13% of left atrial volume)
32 (91.4%) 3 (27.3%) 0.001
LA area (cm2), 3-month follow-up 18.0 5.0 24.4 4.6 0.001
LA volume (cm3), 3-month follow-up 74.1 26.4 110.3 16.8 0.001
A  left atrial.A wall imaging with greater spatial resolution, signal-to-oise ratio, and contrast-to-noise ratio is expected at higher
agnetic field (3-T). Although we found that the degree of
trial enhancement (and presumably scar) and freedom from
ecurrence were linked, we were not able to show whether
his was caused by complete and successful isolation at 3
onths or simply caused by the destruction of electrically
iable tissue to such an extent that the atrium could no
onger sustain AF. The standard ablation procedure at our
acility incorporates both of these techniques, and as a
esult, we were unable to differentiate the relative contribu-
ions. Prospective studies designed to pursue this question
hould be conducted.
onclusions
oninvasive imaging of the LA wall with MRI is a recent
dvancement and a powerful tool to evaluate injury related
o RF energy delivery during AF ablation. Results reported
n our study suggest that the degree of LA wall injury
redicts procedural outcome at 3 months.
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trial Fibrillation Program and Electrophysiology Laboratory,
ivision of Cardiology, University of Utah Health Sciences
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